Zipnosis was one of four companies recognized in the recent report – IDC Innovators: U.S. Virtual Care Solutions, 2016 (doc# US41117616, May 2016). IDC Innovators are defined as companies with under $50 million in revenue that offer "an inventive technology and/or groundbreaking new business model."
IDC Innovators reports present a set of vendors chosen by an IDC analyst within a specific market that offer an innovative new technology, a groundbreaking approach to an existing issue, and/or an interesting new business model. It is not an exhaustive evaluation of all companies in a segment or a comparative ranking of the companies. IDC INNOVATOR and IDC INNOVATORS are trademarks of International Data Group, Inc.
Zipnosis offers health systems an industry-leading white-labeled telemedicine platform, providing patients convenient access to care. Leveraging existing health system clinical capacity, patients can be treated through video, telephone or adaptive online interviews. When a lab test like strep is needed, patients are directed to visit a clinic with expedited service using the ZipTicket® boarding pass.
"We are thrilled to be recognized as an IDC Innovator in the virtual care market," said Jon Pearce, CEO and Founder of Zipnosis. "The recognition is especially appreciated because Zipnosis is not a traditional telemedicine provider – we sell a virtual care platform to health systems who brand it for their patients, use their own clinicians, and leverage our integration with electronic health records. We've stripped out the clinical overhead for physicians and made it easy for them to conduct a virtual visit in two minutes with no typing. Not only is it fast and convenient for patients and clinicians, but diagnosis and treatment is highly adherent with clinical guidelines and best practices."
Zipnosis addresses recent critiques of telemedicine quality
Unlike many telemedicine companies, the Zipnosis platform enables healthcare organizations to use their own clinicians to provide virtual care. That approach is starkly different than the alternative "outsourced" model that came under scrutiny this month after stories in The Wall Street Journal and New York Times covered two separate peer-reviewed studies that questioned the quality of care and adherence to clinical guidelines delivered by outsourced video- and phone-based telemedicine physicians.
By contrast, a Zipnosis study of 1,760 patient virtual care visits at two large health systems found that the company's adaptive online interview model resulted in 95 percent adherence to clinical guidelines in the treatment of acute sinusitis.
Zipnosis partners with health systems nationwide to provide a white-labeled telemedicine virtual care platform, offering patients convenient access to care while improving clinician efficiency. Patients can be virtually treated for more than 90 conditions using evidence-based adaptive interviews, phone or video, or when a rapid test like strep is needed, directed to visit a clinic with expedited service using the ZipTicket® boarding pass. Based in Minnesota, Zipnosis has more than seven years' experience and data to help our partners rapidly launch and scale a market-leading virtual care solution. For more information, visit www.zipnosis.com.
Amendola Communications for Zipnosis
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/zipnosis-named-an-idc-innovator-in-us-virtual-care-300274457.html